Dalit Ayali-Strauss
Ra'anana, M, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Pharmacokinetics of UGN‑102, an investigational mitomycin‑containing reverse thermal gel for the treatment of non-muscle invasive bladder cancer.
Journal: Cancer chemotherapy and pharmacology
Published: March 19, 2025
Durability of Response to Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-Containing Reverse Thermal Gel: OLYMPUS Trial Final Report.
Journal: The Journal of urology
Published: December 17, 2021
Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial.
Journal: The Lancet. Oncology
Published: December 20, 2019
Assessment of the efficacy of repeated instillations of mitomycin C mixed with a thermosensitive hydrogel in an orthotopic rat bladder cancer model.
Journal: Therapeutic advances in urology
Published: October 05, 2017
Serial retrograde instillations of sustained release formulation of mitomycin C to the upper urinary tract of the Yorkshire swine using a thermosensitive polymer: Safety and feasibility.
Journal: Urologic oncology
Published: August 29, 2016
On-site education of VEGF-recruited monocytes improves their performance as angiogenic and arteriogenic accessory cells.
Journal: The Journal of experimental medicine
Published: October 30, 2013
Serum ferritin and paraoxonase-1 in canine leishmaniosis.
Journal: Comparative immunology, microbiology and infectious diseases
Published: May 22, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026